Literature DB >> 18498610

The efficacy of indoor CDC light traps for collecting the sandfly Phlebotomus argentipes, vector of Leishmania donovani.

D S Dinesh1, P DAS, A Picado, C Davies, N Speybroeck, M Boelaert, M Coosemans.   

Abstract

The efficacy of light traps for collecting sandflies (Diptera: Psychodidae) varies both inter-specifically and intra-specifically (by gender and physiological status) as a result of significant differences in phototropic and other behavioural characteristics. The efficacy of miniature CDC light traps for collecting Phlebotomus argentipes Annandale & Brunetti, a vector of Leishmania donovani Laveran & Mesnil (Kinetoplastida: Trypanosomatidae), was assessed in the Indian state of Bihar. Sandflies were collected during the night from 16 houses in each of three villages over 3 months (four times at fortnightly intervals) using CDC light traps indoors, and by aspirator collection (carried out by one person for 30 min/house) from the walls of the same houses the following morning. Incidence rate ratios (IRRs) between CDC light trap collections and aspirator collections were obtained through a negative binomial regression with household as random effect. CDC light traps were especially effective in catching males (IRR 3.08, 95% confidence interval [CI] 2.12-4.46) and unfed females (IRR 3.50, 95% CI 2.37-5.16) of P. argentipes, and to a lesser extent gravids (IRR 1.77, 95% CI 1.07-2.93). However, only a relatively small proportion of all blood-fed P. argentipes were collected by light trap (IRR 0.45, 95% CI 0.28-0.73). Despite its limitations in collecting blood-fed female sandflies, the CDC light trap appears to trap a sufficient proportion of the indoor population of sandflies for sampling purposes, and as this light trap is also more convenient and more easily standardized than the aspirator method, we conclude that it is the most efficient method for monitoring P. argentipes populations in the Indian subcontinent.

Entities:  

Mesh:

Year:  2008        PMID: 18498610     DOI: 10.1111/j.1365-2915.2008.00724.x

Source DB:  PubMed          Journal:  Med Vet Entomol        ISSN: 0269-283X            Impact factor:   2.739


  14 in total

1.  IDENTIFICATION OF CANINE VISCERAL LEISHMANIASIS IN A PREVIOUSLY UNAFFECTED AREA BY CONVENTIONAL DIAGNOSTIC TECHNIQUES AND CELL-BLOCK FIXATION.

Authors:  Tuanne Rotti Abrantes; Maria de Fátima Madeira; Denise Amaro da Silva; Carolina dos Santos F S Perié; Artur Augusto V Mendes Júnior; Rodrigo Caldas Menezes; Valmir Laurentino Silva; Fabiano Borges Figueiredo
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-02-23       Impact factor: 1.846

2.  The Indian and Nepalese programmes of indoor residual spraying for the elimination of visceral leishmaniasis: performance and effectiveness.

Authors:  R Chowdhury; M M Huda; V Kumar; P Das; A B Joshi; M R Banjara; S Akhter; A Kroeger; B Krishnakumari; M Petzold; D Mondal; M L Das
Journal:  Ann Trop Med Parasitol       Date:  2011-01

3.  Effect of village-wide use of long-lasting insecticidal nets on visceral Leishmaniasis vectors in India and Nepal: a cluster randomized trial.

Authors:  Albert Picado; Murari L Das; Vijay Kumar; Shreekant Kesari; Diwakar S Dinesh; Lalita Roy; Suman Rijal; Pradeep Das; Mark Rowland; Shyam Sundar; Marc Coosemans; Marleen Boelaert; Clive R Davies
Journal:  PLoS Negl Trop Dis       Date:  2010-01-26

4.  wsp-based analysis of Wolbachia strains associated with Phlebotomus papatasi and P. sergenti (Diptera: Psychodidae) main cutaneous leishmaniasis vectors, introduction of a new subgroup wSerg.

Authors:  Fateh Karimian; Hassan Vatandoost; Yavar Rassi; Naseh Maleki-Ravasan; Nayyereh Choubdar; Mona Koosha; Kourosh Arzamani; Eslam Moradi-Asl; Arshad Veysi; Hamzeh Alipour; Manouchehr Shirani; Mohammad Ali Oshaghi
Journal:  Pathog Glob Health       Date:  2018-05-10       Impact factor: 2.894

5.  Toolkit for monitoring and evaluation of indoor residual spraying for visceral leishmaniasis control in the Indian subcontinent: application and results.

Authors:  M Mamun Huda; Dinesh Mondal; Vijay Kumar; Pradeep Das; S N Sharma; Murari Lal Das; Lolita Roy; Chitra Kumar Gurung; Megha Raj Banjara; Shireen Akhter; Narayan Prosad Maheswary; Axel Kroeger; Rajib Chowdhury
Journal:  J Trop Med       Date:  2011-07-27

6.  Serological markers of sand fly exposure to evaluate insecticidal nets against visceral leishmaniasis in India and Nepal: a cluster-randomized trial.

Authors:  Kamlesh Gidwani; Albert Picado; Suman Rijal; Shri Prakash Singh; Lalita Roy; Vera Volfova; Elisabeth Wreford Andersen; Surendra Uranw; Bart Ostyn; Medhavi Sudarshan; Jaya Chakravarty; Petr Volf; Shyam Sundar; Marleen Boelaert; Matthew Edward Rogers
Journal:  PLoS Negl Trop Dis       Date:  2011-09-13

7.  Chemical and environmental vector control as a contribution to the elimination of visceral leishmaniasis on the Indian subcontinent: cluster randomized controlled trials in Bangladesh, India and Nepal.

Authors:  Anand B Joshi; Murari L Das; Shireen Akhter; Rajib Chowdhury; Dinesh Mondal; Vijay Kumar; Pradeep Das; Axel Kroeger; Marleen Boelaert; Max Petzold
Journal:  BMC Med       Date:  2009-10-05       Impact factor: 8.775

Review 8.  Vector control interventions for visceral leishmaniasis elimination initiative in South Asia, 2005-2010.

Authors:  Albert Picado; Aditya P Dash; Sujit Bhattacharya; Marleen Boelaert
Journal:  Indian J Med Res       Date:  2012-07       Impact factor: 2.375

9.  An outbreak investigation of visceral leishmaniasis among residents of Dharan town, eastern Nepal, evidence for urban transmission of Leishmania donovani.

Authors:  Surendra Uranw; Epco Hasker; Lalita Roy; Filip Meheus; Murari Lal Das; Narayan Raj Bhattarai; Suman Rijal; Marleen Boelaert
Journal:  BMC Infect Dis       Date:  2013-01-18       Impact factor: 3.090

10.  Do Size and Insecticide Treatment Matter? Evaluation of Different Nets against Phlebotomus argentipes, the Vector of Visceral Leishmaniasis in Nepal.

Authors:  Murari Lal Das; Mark Rowland; James W Austin; Elisa De Lazzari; Albert Picado
Journal:  PLoS One       Date:  2014-12-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.